Wegovy reduces knee pain in osteoarthritis patients with obesity, study finds

Semaglutide, better known as Ozempic and Wegovy, helped alleviate pain from knee osteoarthritis and improve function in patients with severe obesity, a new study found. 

The results of the 68-week trial were published in the New England Journal of Medicine, and could pave the way for a future FDA approval of GLP-1 receptor agonists for the joint-degrading condition. 

Read the rest…